GSK Pharma appoints Bhushan Akshikar as MD

Don't want to miss the best from Business Standard?

Glaxosmithkline Pharmaceuticals said that the board of directors has appointed Bhushan Akshikar as the managing director (MD) of the company with effect from 1 December 2022 for a period of four years.

Bhushan Akshikar will be replacing Sridhar Venkatesh, who is moving to a new senior role within GSK Group effective from the same date as well, said the pharma company.

Bhushan Akshikar is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry. Prior to joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson in various roles leading both specialty and primary care business units in local and regional positions living in India, South Korea and Belgium.

GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies.

The pharmaceutical firm's consolidated net profit declined 1.5% to Rs 119.28 crore on a 3.7% rise in net sales to Rs 745.10 in Q1 FY23 over Q1 FY22.

The scrip declined 0.07% to end at Rs 1,377.60 on the BSE.

Powered by Capital Market - Live News